Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study

Digestive and Liver Disease

Volumn 41, Issue 5, 2009, Pages 350-356

  Burra, P ^a   Senzolo, M ^a   Masier, A ^a   Prestele, H ^b   Jones, R ^c   Samuel, D ^d   Villamil, F ^e  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b NOVARTIS PHARMA AG   (Switzerland)

^c AUSTIN HOSPITAL   (Australia)

^d HÔPITAL PAUL BROUSSE   (France)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Cyclosporine; Hepatitis C virus; Liver transplant; Renal function

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE FACTORS; ANTIVIRAL AGENTS; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HEPATITIS C; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63049118746     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.09.018     Document Type: Article

References (36)

1. Nair S., Verma S., and Thuluvath P.J. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35 (2002) 1179
2. Sanchez E.Q., Gonwa T.A., Levy M.F., Goldstein R.M., Mai M.L., Hays S.R., et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 78 (2004) 1048
3. Ojo A.O., Held P.J., Port F.K., Wolfe R.A., Leichtman A.B., Young E.W., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931
4. Velidedeoglu E., Bloom R.D., Crawford M.D., Desai N.M., Campos L., Abt P.L., et al. Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation 77 (2004) 553
5. McCauley J., Van Thiel Dh., Starzl T.E., and Puschett J.B. Acute and chronic renal failure in liver transplantation. Nephron 55 (1990) 121
6. Fisher N.C., Nightingale P.G., Gunson B.K., Lipkin G.W., and Neuberger J.M. Chronic renal failure following liver transplantation. Transplantation 66 (1998) 59
7. Randhawa P.S., and Shapiro R. Chronic renal failure after liver transplantation. Am J Transplant 5 (2005) 967
8. Burdmann E.A., Andoh T.F., Yu L., and Bennett W.M. Cyclosporine nephrotoxicity. Semin Nephrol 23 (2003) 465-476
9. Kopp J.B., and Klotman P.E. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1 (1990) 162-179
10. Pillebout E., Nochy D., Hill G., Conti F., Antoine C., Calmus Y., et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 5 (2005) 1120
11. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
12. Hetz H., Bauer M., Lahner D., Faybik P., Winning J., Ankersmit H.J., et al. Endothelin activation and postoperative renal failure after human liver transplantation. Liver Transpl 11 (2005) 1201
13. Ojea D., Gago González E., Díaz Corte C., Díaz Molina B., Dieguez L., Ortega F., et al. Study of renal function in nonrenal organ transplantation. Transpl Proc 38 (2006) 2985-2988
14. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
15. Cohen A.J., Stegall M.D., Rosen C.B., Wiesner R.H., Leung N., Kremers W.K., et al. Chronic renal dysfunction late after liver transplantation. Liver Transpl 8 (2002) 916
16. Salvadori M., Rosati A., Bock A., Chapman J., Dussol B., Fritsche L., et al. One year post-transplant renal function is a strong predictor of long-term kidney function: results from the Neoral MOST observational study. Transpl Proc 35 (2003) 2863
17. Salvadori M., Rosati A., Bock A., Chapman J., Dussol B., Fritsche L., et al. Estimated one year glomerular filtration rate is the best predictor of long-term graft function following renal transplantation. Transplantation 81 (2006) 202
18. Pawarode A., Fine D.M., and Thuluvath P.J. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 9 (2003) 741-747
19. Gonwa T.A., Mai M.L., Melton L.B., Hays S.R., Goldstein R.M., Levy M.F., et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 72 (2001) 1934-1939
20. Guitard J., Ribes D., Kamar N., Cointault O., Lavayssiere L., Esposito L., et al. Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail 28 (2006) 419-425
21. Komatsuda A., Imai H., Wakui H., Hamai K., Ohtani H., Kodama T., et al. Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy. Intern Med 35 (1996) 529-533
22. Aberg F., Koivusalo A.M., Hockerstedt K., and Isoniemi H. Renal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic disease. Transpl Int (2007) 591-599
23. Braun N., Dette S., and Viebahn R. Impairment of renal function following liver transplantation. Transpl Proc 35 (2003) 1458-1460
24. Asfandiyar S., Abouljoud M., Kim D., Brown K., Yoshida A., Arenas J., et al. Influence of hepatitis C on renal function after liver transplantation. Transpl Proc 38 (2006) 3643-3645
25. Kendrick E.A., McVicar J.P., Kowdley K.V., Bronner M.P., Emond M.J., Alpers C.E., et al. Renal disease in hepatitis-C positive liver transplant recipients. Transplantation 63 (1997) 1287
26. Abrahamian G.A., Cosimi A.B., Farrell M.L., Schoenfeld D.A., Chung R.T., and Pascual M. Prevalence of hepatitis C virus-associated cryoglobulinemia after liver transplantation. Liver Transpl 6 (2000) 185
27. Gane E.J., Portmann B.C., Naoumov N.V., Smith H.M., Underhill J.A., Donaldson P.T., et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334 (1996) 815
28. Pascual M., Thadhani R., Chung R.T., Williams W.W., Meehan S., Tolkoff-Rubin N., et al. Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation 64 (1997) 1073
29. Kasiske B.L., and Snyder J.J. Hepatitis C and kidney transplantation in the United States, 1995-2002. Am J Transpl 5 s11 (2005) 558 [abstract 1579]
30. Mahmoud I.M., Elhabashi A.F., Elsawy E., Sheha G., and Sobh M.A. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 43 (2004) 131
31. Opelz G., Wujciak T., and Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 53 (1998) 217
32. Distant D.A., and Gonwa T.A. The kidney in liver transplantation. J Am Soc Nephrol 4 (1993) 129
33. Montalbano M., Neff G.W., Yamashiki N., Meyer D., Bettiol M., Slapak-Green G., et al. A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation 78 (2004) 264
34. Vivarelli M., Vetrone G., Zanello M., Barba G.L., Cucchetti A., Lauro A., et al. Sirolimus as the main immunosuppressant in the early postoperative period following liver transplantation: a report of six cases and review of the literature. Transpl Int 19 (2006) 1022-1025
35. Kamar N., Frimat L., Blancho G., Wolff P., Delahousse M., and Rostaing L. Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency. Transpl Int (2007) 128-134
36. Gonwa T.A., Jennings L., Mai M.L., Stark P.C., Levey A.S., and Klintmalm G.B. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 301-309